Inside informationEnglish
AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 12/06/2025, 07:59
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112239_20250612